View in EDS

Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non–small-cell lung cancer.

Saved in:
Bibliographic Details
Title: Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non–small-cell lung cancer.
Authors: Liu, Stephen V.1 Stephen.V.Liu@gunet.georgetown.edu, Camidge, D. Ross2 ross.camidge@ucdenver.edu, Gettinger, Scott N.3 scott.gettinger@yale.edu, Giaccone, Giuseppe1 gg496@georgetown.edu, Heist, Rebecca S.4 rheist@partners.org, Hodi, F. Stephen5 Stephen_Hodi@dfci.harvard.edu, Ready, Neal E.6 neal.ready@duke.edu, Zhang, Wei7 zhang.wei_zhanw107@gene.com, Wallin, Jeffrey7 jwallin@seagen.com, Funke, Roel7 funke.roel@gene.com, Waterkamp, Daniel7 waterkamp.daniel@gene.com, Foster, Paul7 foster.paul@gene.com, Iizuka, Koho7 iizuka.koho@gene.com, Powderly, John8 jpowderly@carolinabiooncology.org
Source: European Journal of Cancer. Sep2018, Vol. 101, p114-122. 9p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2018.06.033